Skip to content

Rhythm Pharmaceuticals

US · RYTM #1874 by market cap Listed 2017
88.45 -2.32 -2.56%
Live - 5344 symbols - heartbeat 407s ago · 2026-10-08 07:27
Pre-market 88.00 -0.51%
After-hours 88.45 0.00%
Overnight 88.34 -0.12%
Market cap
6.09B
P/B
59.12
EPS
-3.11
Reader sentiment Are you bullish or bearish on RYTM?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    A Quick Look at Today's Ratings for Rhythm Pharmaceuticals(RYTM.US), With a Forecast Between $130 to $160
    Market Newswire · 2026/8/5
  • Rating change
    Wolfe Research Initiates Rhythm Pharmaceuticals(RYTM.US) With Buy Rating
    Market Newswire · 2026/9/17
  • Rating change
    Morgan Stanley Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $150
    Market Newswire · 2026/8/25
  • J.P. Morgan Remains a Buy on Rhythm Pharmaceuticals (RYTM)
    TipRanks · 2026/9/16
  • Rating change
    Guggenheim Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $143
    Market Newswire · 2026/8/25
  • Rating change
    Morgan Stanley Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $150
    Market Newswire · 2026/8/5
  • Rating change
    A Quick Look at Today's Ratings for Rhythm Pharmaceuticals(RYTM.US), With a Forecast Between $105 to $159
    Market Newswire · 2026/6/15
  • Rating change
    TD Cowen Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $130
    Market Newswire · 2026/6/17
  • Rating change
    CCORF Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $151
    Market Newswire · 2026/7/8
  • Rating change
    BofA Securities Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating
    Market Newswire · 2026/7/15
  • Deutsche Bank Initiates Rhythm Pharmaceuticals(RYTM.US) With Hold Rating, Announces Target Price $120
    Market Newswire · 2026/8/28
  • Rating change
    CCORF Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $154
    Market Newswire · 2026/8/5
  • Rating change
    RBC Capital Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $141
    Market Newswire · 2026/7/7
  • J.P. Morgan Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating
    Market Newswire · 2026/9/16
  • Rating change
    J.P. Morgan Initiates Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Announces Target Price $146
    Market Newswire · 2026/8/10
  • RBC Capital Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $155
    Market Newswire · 2026/9/15
  • Form 144 | Rhythm Pharmaceuticals(RYTM.US) Director Proposes to Sell 5.24 Million in Common Stocks
    Market Newswire · 2026/9/15
  • Rating change
    A Quick Look at Today's Ratings for Rhythm Pharmaceuticals(RYTM.US), With a Forecast Between $105 to $155
    Market Newswire · 2026/6/16
  • Rating change
    CCORF Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $151
    Market Newswire · 2026/6/16
  • Rating change
    Wells Fargo Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $155
    Market Newswire · 2026/7/16

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 07:27:07 · For reference only, not investment advice and not tailored to your situation.